Literature DB >> 7686306

Increased activity of L-type Ca2+ channels exposed to serum from patients with type I diabetes.

L Juntti-Berggren1, O Larsson, P Rorsman, C Ammälä, K Bokvist, K Wåhlander, P Nicotera, J Dypbukt, S Orrenius, A Hallberg.   

Abstract

Type I diabetes [insulin-dependent diabetes mellitus (IDDM)] is an autoimmune disease associated with the destruction of pancreatic beta cells. Serum from patients with IDDM increased L-type calcium channel activity of insulin-producing cells and of GH3 cells derived from a pituitary tumor. The subsequent increase in the concentration of free cytoplasmic Ca2+ ([Ca2+]i) was associated with DNA fragmentation typical of programmed cell death or apoptosis. These effects of the serum were prevented by adding a blocker of voltage-activated L-type Ca2+ channels. When the serum was depleted of immunoglobulin M (IgM), it no longer affected [Ca2+]i. An IgM-mediated increase in Ca2+ influx may thus be part of the autoimmune reaction associated with IDDM and contribute to the destruction of beta cells in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7686306     DOI: 10.1126/science.7686306

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  37 in total

1.  Role of Ca2+ in apoptosis evoked by human amylin in pancreatic islet beta-cells.

Authors:  J Z Bai; E L Saafi; S Zhang; G J Cooper
Journal:  Biochem J       Date:  1999-10-01       Impact factor: 3.857

2.  Humoral immunity against glutamic acid decarboxylase and tyrosine phosphatase IA-2 in Lambert-Eaton myasthenic syndrome.

Authors:  L Hermitte; N Martin-Moutot; J Boucraut; R Barone; C Atlan-Gepner; M Seagar; J Pouget; J P Kleisbauer; F Couraud; B Vialettes
Journal:  J Clin Immunol       Date:  2000-07       Impact factor: 8.317

Review 3.  Is the use of some calcium antagonists linked to cancer? Evidence from recent observational studies.

Authors:  M Pahor; C D Furberg
Journal:  Drugs Aging       Date:  1998-08       Impact factor: 3.923

4.  Alterations in basal and glucose-stimulated voltage-dependent Ca2+ channel activities in pancreatic beta cells of non-insulin-dependent diabetes mellitus GK rats.

Authors:  S Kato; H Ishida; Y Tsuura; K Tsuji; M Nishimura; M Horie; T Taminato; S Ikehara; H Odaka; I Ikeda; Y Okada; Y Seino
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

5.  Cytokine-induced apoptotic cell death in a mouse pancreatic beta-cell line: inhibition by Bcl-2.

Authors:  H Iwahashi; T Hanafusa; Y Eguchi; H Nakajima; J Miyagawa; N Itoh; K Tomita; M Namba; M Kuwajima; T Noguchi; Y Tsujimoto; Y Matsuzawa
Journal:  Diabetologia       Date:  1996-05       Impact factor: 10.122

Review 6.  Calcium antagonists and cancer. Is there really a link?

Authors:  L G Howes; C T Edwards
Journal:  Drug Saf       Date:  1998-01       Impact factor: 5.606

7.  Lowering apolipoprotein CIII delays onset of type 1 diabetes.

Authors:  Rebecka Holmberg; Essam Refai; Anders Höög; Rosanne M Crooke; Mark Graham; Gunilla Olivecrona; Per-Olof Berggren; Lisa Juntti-Berggren
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-13       Impact factor: 11.205

Review 8.  The central role of calcium in the effects of cytokines on beta-cell function: implications for type 1 and type 2 diabetes.

Authors:  James W Ramadan; Stephen R Steiner; Christina M O'Neill; Craig S Nunemaker
Journal:  Cell Calcium       Date:  2011-09-23       Impact factor: 6.817

9.  Voltage-dependent calcium currents are enhanced in dorsal root ganglion neurones from the Bio Bred/Worchester diabetic rat.

Authors:  K E Hall; A A Sima; J W Wiley
Journal:  J Physiol       Date:  1995-07-15       Impact factor: 5.182

Review 10.  Voltage-operated calcium channel heterogeneity in pancreatic beta cells: physiopathological implications.

Authors:  E Sher; F Giovannini; A Codignola; M Passafaro; P Giorgi-Rossi; S Volsen; P Craig; A Davalli; P Carrera
Journal:  J Bioenerg Biomembr       Date:  2003-12       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.